SCHEMBL1102739

SCHEMBL1102739

C[Si]1(C)c2ccccc2N(c2c3ccccc3c(N3c4ccccc4[Si](C)(C)c4ccccc43)c3cnccc23)c2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.33
MAOB P27338 5/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ACHE P22303 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
IKBKB O14920 1/20 0.33
AURKA O14965 1/20 0.33
CHUK O15111 1/20 0.33
PIM1 P11309 1/20 0.33
TOP1 P11387 1/20 0.33
GABRA1 P14867 1/20 0.33
IDO1 P14902 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102773 0.92 ALOX5 (0.33) ATMTNF
SCHEMBL1102819 0.87 TNF (0.40) KDM4EALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL1102764 0.85 CYP17A1 (0.36) TDO2
SCHEMBL1102741 0.82 MAOA (0.32) MAOAMAOBKDM4EALDH1A1HPGD
SCHEMBL16314377 0.81 MPO (0.31) MAOAMAOBKDM4EALDH1A1HPGD
SCHEMBL1102517 0.80 ADRA2A (0.38) MAOAMAOBKDM4EALDH1A1HPGD
SCHEMBL1102902 0.78 L3MBTL1 (0.36) KDM4EALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL1102506 0.76 ACHE (0.45) MAOAMAOBKDM4EALDH1A1HPGD
SCHEMBL1102544 0.76 STAT3 (0.38) MAOAMAOBKDM4EALDH1A1HPGD
SCHEMBL1102734 0.76 P2RX4 (0.39) MAOAMAOBKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 MAOA 1588/4885MAOB 1209/4885KDM4E 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.